Abstract
51P Toxicity profile in early clinical trials with fibroblast growth factor receptor (FGFR) inhibitors (FGFRi): 10-years experience of a drug development unit
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have